KN

Kiri North

VI Vertex Pharmaceuticals Incorporated: 5 patents #310 of 896Top 35%
Merck: 3 patents #3,073 of 9,382Top 35%
IH Institute Of Cancer Research: Royal Cancer Hospital: 1 patents #58 of 148Top 40%
Overall (All Time): #777,715 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12258333 N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels Elizabeth Mary Beck, Steven Durrant, Sarah Elizabeth Skerratt, Robert Pullin, Gorka Etxebarria Jardi +19 more 2025-03-25
12084438 GCN2 inhibitors and uses thereof Matthew Bleich, Jean-Damien Charrier, Huijun Dong, Steven Durrant, Meredith Suzanne Eno +11 more 2024-09-10
12018029 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors Leo Leung, Deborah Smithen, Mohammed Aljarah, Michael S. Brown, Ben Ayers +2 more 2024-06-25
11827627 N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels Elizabeth Mary Beck, Steven Durrant, Sarah Elizabeth Skerratt, Robert Pullin, Gorka Etxebarria Jardi +19 more 2023-11-28
10988477 GCN2 inhibitors and uses thereof Andrew Bayly, Matthew Bleich, Jean-Damien Charrier, James Dodd, Steven Durrant +14 more 2021-04-27
10793563 GCN2 inhibitors and uses thereof Matthew Bleich, Jean-Damien Charrier, Huijun Dong, Steven Durrant, Meredith Suzanne Eno +11 more 2020-10-06